TRIO-TECH INTERNATIONAL (TRT) Stock Fundamental Analysis

NYSEARCA:TRT • US8967122057

4.71 USD
-0.15 (-3.09%)
Last: Mar 2, 2026, 04:15 PM
Fundamental Rating

4

Taking everything into account, TRT scores 4 out of 10 in our fundamental rating. TRT was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. While TRT has a great health rating, there are worries on its profitability. TRT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year TRT was profitable.
  • TRT had a positive operating cash flow in the past year.
  • In multiple years TRT reported negative net income over the last 5 years.
  • Each year in the past 5 years TRT had a positive operating cash flow.
TRT Yearly Net Income VS EBIT VS OCF VS FCFTRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M 4M 6M 8M

1.2 Ratios

  • With a Return On Assets value of 0.57%, TRT perfoms like the industry average, outperforming 51.30% of the companies in the same industry.
  • With a Return On Equity value of 0.80%, TRT perfoms like the industry average, outperforming 51.30% of the companies in the same industry.
  • TRT's Return On Invested Capital of 0.17% is in line compared to the rest of the industry. TRT outperforms 48.70% of its industry peers.
  • TRT had an Average Return On Invested Capital over the past 3 years of 2.81%. This is significantly below the industry average of 10.63%.
Industry RankSector Rank
ROA 0.57%
ROE 0.8%
ROIC 0.17%
ROA(3y)2.01%
ROA(5y)2%
ROE(3y)2.82%
ROE(5y)2.96%
ROIC(3y)2.81%
ROIC(5y)N/A
TRT Yearly ROA, ROE, ROICTRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • With a Profit Margin value of 0.64%, TRT perfoms like the industry average, outperforming 51.30% of the companies in the same industry.
  • With a Operating Margin value of 0.18%, TRT perfoms like the industry average, outperforming 48.70% of the companies in the same industry.
  • In the last couple of years the Operating Margin of TRT has declined.
  • TRT has a worse Gross Margin (22.30%) than 78.26% of its industry peers.
  • In the last couple of years the Gross Margin of TRT has grown nicely.
Industry RankSector Rank
OM 0.18%
PM (TTM) 0.64%
GM 22.3%
OM growth 3Y-57.25%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5Y3.52%
TRT Yearly Profit, Operating, Gross MarginsTRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

7

2. Health

2.1 Basic Checks

  • TRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • TRT has more shares outstanding than it did 1 year ago.
  • TRT has more shares outstanding than it did 5 years ago.
  • TRT has a better debt/assets ratio than last year.
TRT Yearly Shares OutstandingTRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRT Yearly Total Debt VS Total AssetsTRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • TRT has an Altman-Z score of 3.81. This indicates that TRT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.81, TRT is in line with its industry, outperforming 52.17% of the companies in the same industry.
  • The Debt to FCF ratio of TRT is 0.29, which is an excellent value as it means it would take TRT, only 0.29 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of TRT (0.29) is better than 81.74% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that TRT is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.01, TRT is doing good in the industry, outperforming 66.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.29
Altman-Z 3.81
ROIC/WACC0.02
WACC10.98%
TRT Yearly LT Debt VS Equity VS FCFTRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • TRT has a Current Ratio of 3.15. This indicates that TRT is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 3.15, TRT perfoms like the industry average, outperforming 53.91% of the companies in the same industry.
  • TRT has a Quick Ratio of 2.95. This indicates that TRT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.95, TRT is doing good in the industry, outperforming 61.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.15
Quick Ratio 2.95
TRT Yearly Current Assets VS Current LiabilitesTRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1

3. Growth

3.1 Past

  • TRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.22%.
  • TRT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.10%.
  • TRT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.14% yearly.
EPS 1Y (TTM)-66.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%143%
Revenue 1Y (TTM)0.1%
Revenue growth 3Y-6.11%
Revenue growth 5Y1.14%
Sales Q2Q%58.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TRT Yearly Revenue VS EstimatesTRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

3

4. Valuation

4.1 Price/Earnings Ratio

  • TRT is valuated quite expensively with a Price/Earnings ratio of 235.50.
  • TRT's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, TRT is valued quite expensively.
Industry RankSector Rank
PE 235.5
Fwd PE N/A
TRT Price Earnings VS Forward Price EarningsTRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TRT is valued cheaply inside the industry as 98.26% of the companies are valued more expensively.
  • TRT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TRT is cheaper than 91.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.48
EV/EBITDA 7.75
TRT Per share dataTRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for TRT!.
Industry RankSector Rank
Dividend Yield 0%

TRIO-TECH INTERNATIONAL

NYSEARCA:TRT (3/2/2026, 4:15:00 PM)

4.71

-0.15 (-3.09%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-13
Earnings (Next)05-11
Inst Owners23.91%
Inst Owner Change-1.65%
Ins Owners25.8%
Ins Owner Change5.46%
Market Cap40.98M
Revenue(TTM)42.19M
Net Income(TTM)272.00K
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 235.5
Fwd PE N/A
P/S 0.97
P/FCF 18.48
P/OCF 12.96
P/B 1.2
P/tB 1.2
EV/EBITDA 7.75
EPS(TTM)0.02
EY0.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.25
FCFY5.41%
OCF(TTM)0.36
OCFY7.71%
SpS4.85
BVpS3.91
TBVpS3.91
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.33
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 0.8%
ROCE 0.22%
ROIC 0.17%
ROICexc 0.34%
ROICexgc 0.34%
OM 0.18%
PM (TTM) 0.64%
GM 22.3%
FCFM 5.26%
ROA(3y)2.01%
ROA(5y)2%
ROE(3y)2.82%
ROE(5y)2.96%
ROIC(3y)2.81%
ROIC(5y)N/A
ROICexc(3y)5.18%
ROICexc(5y)N/A
ROICexgc(3y)5.18%
ROICexgc(5y)N/A
ROCE(3y)3.55%
ROCE(5y)N/A
ROICexgc growth 3Y-59.08%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.08%
ROICexc growth 5YN/A
OM growth 3Y-57.25%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5Y3.52%
F-Score4
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.29
Debt/EBITDA 0.14
Cap/Depr 36.85%
Cap/Sales 2.24%
Interest Coverage 1.86
Cash Conversion 119.74%
Profit Quality 815.07%
Current Ratio 3.15
Quick Ratio 2.95
Altman-Z 3.81
F-Score4
WACC10.98%
ROIC/WACC0.02
Cap/Depr(3y)45.5%
Cap/Depr(5y)44.1%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%143%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.1%
Revenue growth 3Y-6.11%
Revenue growth 5Y1.14%
Sales Q2Q%58.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.33%
EBIT growth 3Y-59.86%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.29%
OCF growth 3Y-44.07%
OCF growth 5Y-34.21%

TRIO-TECH INTERNATIONAL / TRT FAQ

Can you provide the ChartMill fundamental rating for TRIO-TECH INTERNATIONAL?

ChartMill assigns a fundamental rating of 4 / 10 to TRT.


Can you provide the valuation status for TRIO-TECH INTERNATIONAL?

ChartMill assigns a valuation rating of 3 / 10 to TRIO-TECH INTERNATIONAL (TRT). This can be considered as Overvalued.


Can you provide the profitability details for TRIO-TECH INTERNATIONAL?

TRIO-TECH INTERNATIONAL (TRT) has a profitability rating of 3 / 10.


What is the financial health of TRIO-TECH INTERNATIONAL (TRT) stock?

The financial health rating of TRIO-TECH INTERNATIONAL (TRT) is 7 / 10.